Tegobuvir (Compound)

Compound:

tegobuvir (c1f8a167-77b0-4d33-b111-140a00f9910b)

Synonyms:Tegobuvir, 1000787-75-6, 5-((6-(2,4-bis(Trifluoromethyl)phenyl)pyridazin-3-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine, GS-9190, GS-333126, 5NOK5X389M, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-2-(2-fluorophenyl)imidazo[4,5-c]pyridine, 5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-;5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-, Tegobuvir [USAN:INN], UNII-5NOK5X389M

Pubchem:PUBCHEM:23649154

Id:a24465ad-c27a-50d5-bb49-247ea8f53b72

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Tegobuvir's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Tegobuvir.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Tegobuvir.

Results found

Linked to

	Label	Description
	BRD-K26701552-001-01-8 Substance (Entity type)	A Substance
	Tegobuvir negatively regulates S100P Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tegobuvir in similarity relationship with SR57227A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tegobuvir negatively regulates ASS1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tegobuvir positively regulates LGALS1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tegobuvir positively regulates FABP7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tegobuvir negatively regulates KANK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tegobuvir negatively regulates NUDT9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tegobuvir negatively regulates CADM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tegobuvir negatively regulates RTN2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K26701552-001-01-8

Substance (Entity type)

A Substance

Tegobuvir negatively regulates S100P

Knowledge Graph Assertion (Entity type)